Invokana Bone Fractures

The U.S. Food & Drug Administration recently warned against physicians using Invokana for prescriptions, due to its deleterious side-effects, which include bone fractures as a key setback for marketers and the manufacturer.

The FDA issued a warning to indicate that the medication prescription relates to the increase in the likelihood of risks involving Invokana bone fractures, and adverse side-effects on the mineral bone density of the patient.

The FDA approved a few years ago Invokana for treating type-2 diabetes as an effective drug.

In the United States, even at the time of its approval, other deleterious effects including risks of ketoacidosis, heart attack, and damage to the kidneys were known already.

Later, the U.S. Food & Drug Association bolstered warnings for the Invokana medication in the revision of the adverse reactions information of the drug, but neglected to advise patients to change or cease the prescription medication for diabetes without discussing it with a physician first.

Invokana and canagliflozin, generic equivalent prescription medicine, are considered to reduce levels of blood sugar in adults who suffer with type-2 diabetes.

The medication, to be most effective, is to be used with diet and exercise in conjunction.

The medicine is classified as an SGLT2 inhibitor, sodium-glucose cotransporter-2.

The prescription medicine was developed to offer viable treatment for those sustaining type-2 diabetes so they could ward off critical problems including nerve and kidney damage, heart disease and blindness.

From safety evaluations administered, data received after the marketing of Invokana to consumers indicate more adverse reactions to the drug.

The research study entailed over 700 elderly patients tested over a two-year period to discover if any changes occurred to the density of the bone mineral.

The discoveries indicate that many patients developed, three months after taking the prescription medication, fractures.

The research indicated that the drug resulted in loss of mineral density in the bone of the patient in the hip and lower spine which have the likelihood of hastening the process of osteoporosis development.

The most at-risk for Invokana bone fractures seem to post-menopausal women.

Due to recent discoveries, the FDA continues to investigate the association of developing bone fractures and using SGLT-2 inhibitors.

Physicians are advised to take extra caution with the medicine prescription to patients, and discuss the likely risk increase of Invokana bone fractures, if they decide to take the medication.

Striving to acquire the most profits possible, pharmaceutical marketers and companies will quickly market medicines to the marketplace before the drugs are tested adequately, which can often place consumers in critical danger.

Recently, there have been some grave concerns over the safety and efficacy of Invokana, and the deleterious side-effects the drug produces.

Nevertheless, personal injury attorneys can file claims and lawsuits for full compensation on your behalf, if you or a family member sustained injuries as a result of Invokana and other medications for type-2 diabetes, which have resulted in injury, harm, damage, or death.

Contact us for a free consultation or call Anzalone Law Firm PLLC, at: 603.548.3797.